KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Short term Debt (2017 - 2025)

Astrana Health (ASTH) has disclosed Short term Debt for 13 consecutive years, with $47.9 million as the latest value for Q4 2025.

  • Quarterly Short term Debt rose 410.56% to $47.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.9 million through Dec 2025, up 410.56% year-over-year, with the annual reading at $47.9 million for FY2025, 410.56% up from the prior year.
  • Short term Debt hit $47.9 million in Q4 2025 for Astrana Health, roughly flat from $47.9 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $47.9 million in Q3 2025 to a low of $205000.0 in Q2 2021.
  • Historically, Short term Debt has averaged $11.5 million across 5 years, with a median of $6.3 million in 2022.
  • Biggest five-year swings in Short term Debt: crashed 97.84% in 2021 and later skyrocketed 3241.38% in 2024.
  • Year by year, Short term Debt stood at $780000.0 in 2021, then decreased by 20.64% to $619000.0 in 2022, then soared by 3050.24% to $19.5 million in 2023, then plummeted by 51.92% to $9.4 million in 2024, then skyrocketed by 410.56% to $47.9 million in 2025.
  • Business Quant data shows Short term Debt for ASTH at $47.9 million in Q4 2025, $47.9 million in Q3 2025, and $12.5 million in Q2 2025.